Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Debt to Equity (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Debt to Equity for 6 consecutive years, with $0.66 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity rose 39.02% year-over-year to $0.66, compared with a TTM value of $0.66 through Dec 2025, up 39.02%, and an annual FY2025 reading of $0.66, up 39.02% over the prior year.
  • Debt to Equity was $0.66 for Q4 2025 at Treace Medical Concepts, up from $0.6 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.87 in Q4 2022 and bottomed at -$42.74 in Q1 2021.
  • Average Debt to Equity over 5 years is -$1.67, with a median of $0.45 recorded in 2024.
  • The sharpest move saw Debt to Equity plummeted 99.21% in 2021, then skyrocketed 181.03% in 2022.
  • Year by year, Debt to Equity stood at $0.32 in 2021, then skyrocketed by 176.01% to $0.87 in 2022, then crashed by 55.87% to $0.38 in 2023, then grew by 22.87% to $0.47 in 2024, then skyrocketed by 39.02% to $0.66 in 2025.
  • Business Quant data shows Debt to Equity for TMCI at $0.66 in Q4 2025, $0.6 in Q3 2025, and $0.55 in Q2 2025.